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Abstract
Background: Adolescent non-suicidal self-injury (NSSI) is associated with altered sensitivity to experimentally
induced pain. Adolescents engaging in NSSI report greater pain threshold and pain tolerance, as well as lower pain
intensity and pain unpleasantness compared to healthy controls. The experience of pain is associated with reactivity
of both the autonomic nervous system (ANS) and the hypothalamic–pituitary–adrenal (HPA) axis. However, previous
research has not yet systematically addressed differences in the physiological response to experimentally induced
pain comparing adolescents with NSSI and age- and sex-matched healthy controls.
Methods/Design: Adolescents with NSSI and healthy controls undergo repeated painful stimulation with the cold
pressor task. ANS activity is continuously recorded throughout the procedure to assess changes in heart rate and
heart rate variability. Blood pressure is monitored and saliva is collected prior to and after nociceptive stimulation to
assess levels of saliva cortisol.
Discussion: The study will provide evidence whether lower pain sensitivity in adolescents with NSSI is associated
with blunted physiological and endocrinological responses to experimentally induced pain compared to healthy
controls. Extending on the existing evidence on altered pain sensitivity in NSSI, measured by self-reports and
behavioural assessments, this is the first study to take a systematic approach in evaluating the physiological
response to experimentally induced pain in adolescent NSSI.
Trial Registration: Deutsche Register Klinischer Studien, Study ID: DRKS00007807; Trial Registration Date: 13.02.2015
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Background
Non-suicidal self-injury (NSSI) is the self-directed act of
harming one’s own body tissue (i.e., cutting or burning)
without suicidal intent [1]. According to a recent meta-
analysis, the prevalence for NSSI in non-clinical samples is
17.2 % among adolescents, 13.4 % among young adults,
and 5.5 % among adults [2]. A characteristic feature of NSSI
is an alteration of sensitivity to experimentally induced
pain, that is also found in other psychiatric conditions
associated with self-injurious behavior (SIB, i.e., the
intentional, self-directed act of injuring one’s own body
tissue by cutting, burning etc. regardless of the suicidal in-
tent) such as borderline personality disorder (BPD) or sui-
cidal ideation [3]. Individuals engaging in SIB report greater
pain threshold and pain tolerance in addition to lower pain
intensity and pain unpleasantness in comparison to healthy
controls (for a complete review on the literature on pain
sensitivity and SIB see Koenig J, Kaess M, Thayer JF. A
Meta-Analysis of Self-Injurious Behavior and Sensitivity to
Experimentally Induced Pain. Submitted).
Recurrent NSSI is a core feature of BPD [4]. BPD is a se-
vere personality disorder that is often characterized by a
pervasive pattern of impulsivity, emotional instability,
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interpersonal dysfunction and a disturbed self-image [5],
and has an approximate suicide rate of 8–10 % [6]. The
disorder usually emerges during adolescence and continues
into adulthood – it is regarded as both a dimensional
construct and a disorder, and has recently been confirmed
as a diagnosis for adolescents in the new Diagnostic and
Statistical Manual of Mental Disorders (DSM-V, [4]).
Borderline personality pathology underlies repetitive self-
harm in a substantial proportion of young individuals.
More than 30 % of retrospective reports from adults with
BPD indicate childhood-onset of self-injury, with another
30 % who indicate adolescent-onset [7]. BPD can be
diagnosed in the majority of female adolescent inpatients
with repetitive NSSI [8], and the number of BPD criteria
met is predictive of whether or not an adolescent has
engaged in SIB [9].
Autonomic nervous system and hypothalamic–pituitary–
adrenal axis response to acute pain
The experience of acute pain leads to a variety of physio-
logical responses. The reactivity of the autonomic ner-
vous system (ANS) to experimentally induced pain is
best described by an increase of sympathetic activity and
a decrease of parasympathetic activity. Reactivity of the
ANS has been found to be associated with pain sensitiv-
ity [10] and to be a significant predictor of pain toler-
ance [11]. Sympathetic nervous system activity increases
with more intense and painful stimulation [12].
On the other hand, nociception is associated with
response of the hypothalamic–pituitary–adrenal (HPA)
axis. Painful stimulation typically leads to an increase in
cortisol release [13]. However, some studies do not report
an increase in cortisol due to painful stimulation [14]. A
greater cortisol awakening response is associated with
greater sensitivity (i.e., ratings of pain intensity and unpleas-
antness) to experimentally induced pain [15, 16]. Sex differ-
ences have been reported in children, such that cortisol
levels are positively associated with increased pain tolerance
in boys and increased pain sensitivity in girls [17]. Greater
pain reports following nociceptive stimulation are associ-
ated with greater increases in cortisol response [18, 19]. To
conclude briefly, both – the ANS and the HPA axis – are
distinct physiological systems that are involved in the
human response to experimentally induced pain and are
related to pain sensitivity.
Autonomic nervous system and hypothalamic–pituitary–
adrenal axis functioning in NSSI
Compared to healthy controls, both ANS and HPA axis
activity and reactivity to stress seem to be altered in in-
dividuals with NSSI and/or BPD [20, 21] but the data
are inconsistent. BPD patients show a significantly
higher startle response compared to healthy controls
[22]. Other findings suggest lower ANS reactivity to
negative pictures in BPD patients [23]. It has been found
that imagery of disorder-specific scripts can lead to a po-
tentiated startle responses and increased autonomic
arousal in BPD patients compared to healthy controls
[24]. However, other studies found that BPD patients do
not differ from healthy controls in their ANS responses
to standardized photographic slides compared to healthy
controls [25–27]. No previous study has systematically
investigated ANS response to experimentally induced
pain in SIB.
Patients with BPD have shown a higher salivary corti-
sol awakening response and higher total daily cortisol
levels compared to healthy controls [28]. Other studies
suggest that basal cortisol levels are only enhanced in
BPD patients with comorbid post-traumatic stress dis-
order [29], in line with previous research, suggesting that
HPA dysfunctions in BPD appears to be related to child-
hood trauma rather than psychopathology in adulthood
[30]. Experimental studies found that individuals with
BPD showed a hyperresponsiveness of the HPA axis
using a combined dexamethasone/corticotropin-releasing
hormone test, as indicated by enhanced corticotropin and
cortisol response [31]. Such hypersensitivity is further sup-
ported by another study using dexamethasone as an en-
dogenous agent [32]. However, these findings were not
replicated by a later study [33] and the usefulness of such
testing in BPD has been questioned [34]. More recently,
experimental studies using a laboratory stress paradigm
(Trier Social Stress Test) demonstrated an attenuated cor-
tisol response in adults with BPD [35], and similarly, in
adolescent patients with repetitive NSSI [36]. Since the ex-
periences of early chronic stress has previously been
linked to a pattern of HPA axis hyperresponsiveness in
early life, a switch to hyporesponsiveness of the central
and/or peripheral cortisol release may occur later in life
[37]. However, previously no study investigated HPA axis
response to experimentally induced pain in NSSI.
Objective
NSSI is associated with altered sensitivity to experimen-
tally induced pain. There is evidence that ANS and HPA
reactivity is different in NSSI compared to healthy con-
trols – in particular in patients with BPD – although
existing studies are not conclusive. ANS and HPA axis
activity is associated with pain sensitivity to experimen-
tally induced pain, and ANS and HPA axis are reactive
to nociceptive stimulation. However, no study has linked
such findings by exploring ANS and HPA axis reactivity
to experimentally induced pain in NSSI. Thus, the
present study aims to investigate ANS and HPA axis re-
sponse to experimentally induced pain in NSSI patients
compared to age- and sex-matched healthy controls.
We hypothesize, that adolescents with NSSI exhibit
decreased ANS and HPA reactivity to experimentally
Koenig et al. BMC Psychiatry  (2015) 15:150 Page 2 of 8
induced pain compared to healthy controls. Specific-
ally, we hypothesize that the ANS response in adoles-
cents with NSSI will show blunted sympathetic but
greater parasympathetic activity in response to painful
stimulation.
Addressing potential differences in the physiological
and endocrinological response to pain in individuals
engaging in SIB might help to enlighten mechanisms
underlying the well know differences on self-reports and
behavioral measures of pain sensitivity. Previous research
on pain response in SIB did not systematically address this
autonomic component and predominantly focused on the
motivational and emotional domains. However, ANS and
HPA responses to pain are well known to shape the indi-
vidual pain experience and thus might further contribute
to altered pain sensitivity in individuals engaging in SIB.
Secondly, each participant will undergo a repeated stimu-
lation after a 25-min washout period to address potential
differences in the habituation to painful experiences.
Methods/Design
The study is an experimental laboratory trial utilizing a
case control-group design, comparing adolescents with
NSSI to age- and sex-matched healthy controls. A priori
power analysis based on previous studies and meta-
analysis of reported group effects (Koenig J, Kaess M,
Thayer JF. A Meta-Analysis of Self-Injurious Behavior and
Sensitivity to Experimentally Induced Pain. Submitted)
helped to determine the aimed sample size of 30 partici-
pants per group.
General procedures
Adolescents with NSSI and age- and sex-matched
healthy controls are enrolling in the study. After recruit-
ment, participants undergo an initial baseline assessment
and diagnostic screening. The experimental procedure
comprises the repeated stimulation (twice) with a cold
pain stimulus to assess pain sensitivity. Physiological re-
cordings of ANS activity are taken throughout painful
stimulation. Endronicological assessments of salivary
cortisol, indexing HPA axis reactivity, occurs before and
after each trial of painful stimulation. Additionally, we
ask participants to complete several self-report question-
naires to control for potential covariates of pain sensitiv-
ity and physiological reactivity. All clinical and baseline
assessments are carried out at the Ambulanz für Risiko-
verhalten & Selbstschädigung (AtRiSk) at the Clinic of
Child and Adolescent Psychiatry, Centre of Psychosocial
Medicine, University of Heidelberg. The experimental
procedures are carried out at the Lab for Pain Research,
at the School of Therapeutic Sciences, at the SRH
University, Heidelberg, Germany.
Ethical approval and recruitment of participants
We received ethic approval to conduct the study out-
lined in this research protocol by the Ethical Committee
of the Medical Faculty, Heidelberg University, Germany
(study ID S-471/2013). Participants (aged 12 to 17 years)
in the NSSI group (n = 30) are recruited consecutively
from the specialized outpatient clinic for risk-taking and
self-harm behaviour (AtRiSk; Ambulanz für Risikover-
halten & Selbstschädigung) at the Clinic of Child and
Adolescent Psychiatry, Centre of Psychosocial Medicine,
University of Heidelberg. For the healthy control group
(n = 30), age- and sex-matched participants are recruited
via public advertisements according to a standardized
procedure within the clinic. Recruitment is restricted to
females given the known sex differences in prevalence of
NSSI and in HPA axis response to stress [38]. Informa-
tion material is prepared to inform adolescents and their
relatives about the aim of the study. Information mater-
ial is available for potential participants of the healthy
control group and the NSSI group. We obtain written
informed consent from adolescents and their first-degree
relatives prior to inclusion in the study. Participants re-
ceive 30€ for participating in the study.
Clinical diagnostics and baseline assessment
We recruit adolescents with NSSI, reporting NSSI be-
havior on at least five days during the past 12 months, at
the AtRiSk clinic who undergo a standardized psycho-
logical assessment. Aside from the assessment of basic
socio-demographic variables, assessments include: the
German version of the Self-Injurious Thoughts and
Behavior Interview (SITBI-G) for the detailed assessment
of NSSI, the German version of the Mini-International
Neuropsychiatric Interview for Children and Adolescents
(M.I.N.I- KID 6.0); the respective part of the German
version of the Structured Clinical Interview for DSM-IV-
Axis II (SKID-II) to assess borderline personality disorder;
the Children’s Global Assessment Scale (C-GAS), a
German depression inventory for children and adolescents
(Depressions-Inventar für Kinder und Jugendliche,
[Depression Inventory for Children and Adolescents]
DIKJ); and the Childhood Experience of Care and Abuse
Questionnaire (CECA.Q).
The SITBI-G [39] is a semi-structured interview for
the assessment of the presence, frequency, and charac-
teristics of a wide range of self-injurious thoughts and
behaviors, including suicidal ideation, suicide plans, sui-
cide gestures, suicide attempts, and NSSI, and shows ex-
cellent psychometric properties. Clinical diagnoses are
assessed using the M.I.N.I- KID [40] and one part of the
SKID-II [41]. The M.I.N.I.-KID is a short structured
diagnostic interview for DSM-IV and ICD-10 psychiatric
disorders for children and adolescents aged 6 to 19 years.
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The borderline- personality disorder portion of the
SKID-II interview is used.
The C-GAS [42] is a widely used numeric rating scale
(1 through 100) to rate the general functioning of chil-
dren under the age of 18. The DIKJ [43] is a German
screening inventory for depressive symptoms in children
and adolescents, based on the Children’s Depression In-
ventory [44]. It comprises 26 items that are rated on
three-point scales and aggregated into a total score. It
has shown to have excellent psychometric properties
[43]. The CECA.Q [45] obtains information on current
relationships and retrospective information on family ar-
rangements and parental loss during childhood focusing
on the life period prior to the age of 17. Screening ques-
tions assess physical and sexual abuse and two scales
measure antipathy and neglect by the mother and father
figure. The German version of the CECA.Q [46] is used.
Participants recruited for the control group, also
complete screening questions of the SITBI, are rated on
the C-GAS, complete the DIKJ and the CECA.Q. In
addition, they complete the structured clinical interview
(SCID-N/P [47]), for DSM-IV-TR non-patient edition, to
control for the presence of any psychiatric disorder.
Cold pain stimulation
Cold pain sensitivity is assessed twice via a previously
evaluated [48] cold pressor task (CPT) procedure. Partic-
ipants are asked to immerse their hand up to the wrist
in an acrylic glass tank with circulating water (three
floor pumps Conrad Electronic GmbH AP-333, water
flow: each 200 l/h) to prevent local warming. The
immersion of the dominant or non-dominant hand is
cross-randomized across trials. There is a 25-min wash-
out period between trials. Water temperature of the
CPT is kept at 4 °C and controlled constantly with a
chilling device (Resun CL 450) and water pump (Conrad
Electronic GmbH Item no. 55 16 73, 1400 l/h) and mea-
sured with two digital underwater thermometers (range
of temperature: −40 to 150 °C) with a built-in 100mAh
lithium battery (Thermograph TEMPr B, B080169) at
different spots (chiller inflow, chiller outflow). Water
temperature is recoded continuously (every second) by
each thermometer and transferred to a PC-based soft-
ware via USB hub. Participants are instructed to keep
their hand open (rather than closed, fist position) while
it is in the water. Before the immersion, the participants
are told to keep the hand in the water until cold pressor
pain turns intolerable, with a cutoff time of 4 min. The
latencies to the first pain sensation (pain threshold) and
to the intolerable pain (pain tolerance) are measured
with a stopwatch in seconds. Ambient temperature was
recorded before the start of the procedure to control for
potential covariates. Prior to nociceptive stimulation a
check-list asking for potential covariates of physiological
response due to cold stimulation and reasons for exclu-
sion from the study is completed. Participants are asked
for the presence of any cardiovascular disease, hyperten-
sion, past cramp attacks or blackouts, chilblains, known
Reynaud syndrome, open wounds, or fracture of the
hands. Their weight and height is recorded to calculate
their body mass index (BMI) that is an important covari-
ate of ANS activity [49]. We ask them to indicate their
dominant hand and if they previously took part in a
study comprising experimental painful stimulation, spe-
cifically using the CPT.
Autonomic nervous system and endocrinological assays
Hear rate (HR) is continuously recorded throughout the
procedures with a Polar RS800CX portable device using
a transmitter consisting of a stable polyamide case with
electrodes attached to an elastic belt fixated to the chest
of participants. Chronotropic control of the heart is
achieved via the complex interplay of the sympathetic
(SNS) and the parasympathetic (PNS) branches of the
ANS. HR is under tonic inhibitory control (PNS domin-
ance over SNS influences) [50], and the PNS modulation
of the HR is fast (timescale of milliseconds) and short-
lived, while SNS effects are slow on the timescale of sec-
onds [51]. The recording and analysis of the sequence of
time intervals between adjacent heartbeats – the inter-
beat-interval (IBI in milliseconds) - is therefore the basis
for the calculation of all the measures of heart rate vari-
ability (HRV). HRV is a reliable and readily available
measure of parasympathetic nervous system activity that
typically decreases after painful stimulation [52]. The
Polar RS800CX is capable to produce IBIs at sampling
frequency of 1000 Hz, providing a temporal resolution
of 1 ms for each R–R interval. Device-specific software
(Polar ProTrainer 5) is used to transfer recordings to a
PC. IBI data (.txt files) is exported and HRV is analyzed
using Kubios HRV (Biosignal Analysis and Medical Imaging
Group, University Kuopio, Finland, Version 2.0) [53].
Different indices of HRV are subsequently derived for
further analysis. Given our particular interest in vagal
activity, the square root of the mean squared difference
of successive NN intervals (RMSSD, ms), the proportion
of pairs of successive NNs that differ by more than
50 ms (pNN50, %), and the spectral power expressed as
normalized units of the high-frequency (HFn.u.; 0.15–
0.4 Hz) band derived using a autoregressive algorithm
are obtained. In case of screwed distributions, HRV data
will be log-transformed for further statistical analysis
[54]. We derive HR and HRV for different time seg-
ments in the course of the procedure. There is a 5 min
baseline recording before hand-immersion in the CPT
and a 10 min post-line recording after hand-removal
from the CPT. In addition to the continuous assessment
of HR and HRV, blood pressure (BP) is measured for a
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total of four times, initiated at least 5 min before each
CPT and immediately after hand removal using an auto-
mated digital device (Braun ExactFit™ 3 BP6000). We
use an estimation of systolic and diastolic BP values, in
addition to mean arterial pressure (MAP), for further
analysis.
We assess HPA axis response using salivary samples.
Saliva cortisol is a reliable and valid proxy of free plasma
cortisol levels [55, 56], sensitive to changes in HPA axis
activation due to stressors [55] such as experimentally
induced pain [57], and has previously been utilised in
numerous studies with children and adolescents [58–60].
We collect four salivary samples; one prior to each CPT
and one following 15 min after hand removal. Collection
of saliva samples is carried out by having participants
chew on a cotton role (Salivettes; Sarstedt, Numbrecht,
Germany) for 2 min. After the collection of salvia, samples
(at least 1000 μl salvia) are labelled with the participant ID
and time-point of assessment, and then are directly deep-
freezed at −20 ° C and stored until assay. Cortisol will be
analysed at the Institute of Pharmacology of the
Medical Faculty Heidelberg (Steroid Lab). For prepar-
ation, samples will be centrifugated for 7 min at
3000 rpm and 100 μl salvia per participant will be used
for assay. The assay for the determination of salvia
cortisol and serum cortisol is a special in-house assay
with extraction and subsequent radioimmunoassay
(RIA) developed by the Steroid Lab at the Institute of
Pharmacology of the Medical Faculty Heidelberg. The
range of the standard curve is from 2,5 to 5000 pg
including a limit of detection of 5 pg/probe. The intra-
assay coefficient of variation is below 10 % and inter-
assay coefficient of variation is below 15 %.
Self-report questionnaires and additional scales
The German version [61] of the short form McGill Pain
Questionnaire (SF-MPQ [62]), is administered after the
each CPT. The SF-MPQ was derived from the McGill
Pain Questionnaire (MPQ [63]), and allows quantitative,
multidimensional pain ratings to be obtained in a brief
period of time. The SF-MPQ consists of 15 descriptors
(11 sensory, 4 affective) that are rated on a 4-point inten-
sity scale from zero (“none”) to three (“severe”). Three
pain scores (sensory, affective, and total descriptors) are
derived from the sum of the intensity rank values of the
words chosen for descriptors. Pain intensity on hand re-
moval is assessed on a 10 cm visual analogue scale
(VAS) from zero to ten, and the overall pain experience
is assessed by one descriptor (“no pain”, “mild”, “discom-
forting”, “distressing”, “horrible”, or “excruciating”). In
addition, participants complete the Quick Inventory of
Pain Symptoms (QIPS) on arrival at the pain laboratory
that assesses pain symptoms in 5 major locations during
the past week [64]. Finally, participants rate three self-
developed scales on arrival at the pain laboratory and
after each CPT. Participants rate their momentary mood
(“Wie geht es dir gerade?”), their felt tension (“Wie hoch
ist deine Anspannung?”), and their body-awareness (“Wie
sehr spürst du dich gerade?”), each on a 10 cm VAS
ranging from 0 to 100.
Data analysis
We will assess group differences in cardiovascular and
endocrinological responses to experimentally induced
pain, by comparing measures taken before and after pain
induction as primary study outcome. Analysis will be
conducted using a repeated measures approach explor-
ing the main and interaction effects of the time of meas-
urement (i.e., pre, post painful stimulation) and group
(i.e., NSSI, healthy controls) on all dependent variables
(i.e., cortisol, RMSSD, MAP) controlling for potential co-
variates (i.e., BMI). Further analysis will address group
differences on reports of pain threshold and pain toler-
ance, as well as self-reports of pain intensity. Exploratory
analysis will address changes in self-rated mood, tension,
and body-awareness comparing assessments taken be-
fore and after pain induction and their association to
physiological reactivity as well as self-reports of pain
experience.
Discussion
The present study aims to investigate differences in
ANS- and HPA-axis response to experimentally induced
cold pain in adolescents with NSSI compared to a sam-
ple of age- and sex-matched healthy controls. Differ-
ences on pain sensitivity in induced thermal cold pain in
SIB have previously been studied [65–74]. However,
none of the previous studies aimed to investigate differ-
ences in the physiological response to nociception using
measures of ANS or HPA axis activity, that are known
to differ in individuals fulfilling clinical criteria for NSSI
and/or BPD.
We decided to use cold pain stimulation via the CPT
as nociceptive stimuli, as it is a well-established experi-
mental procedure [75] to induce cold pain and is ethic-
ally acceptable also in the use with younger participants
[76–78], developed originally as a clinically indicative
cardiovascular test, and thus, produces a reliable ANS
response [79–82]. Different temperatures are proposed
for the use of the CPT [83]. Studies on NSSI used temper-
atures as high as 10 °C [65] to as low as 0 °C [71] – all
producing significant differences between individuals en-
gaging in SIB and healthy controls. We decided to use a
temperature of 4 °C, as it previously produced the most
reliable results using this apparatus [48]. Participants of
the present study receive repeated stimulation with the
CPT, to control for lateral dominance and differences be-
tween both hands (dominant vs. non-dominant) that have
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previously been supported by some studies [84–87]. Fur-
thermore, this will allow for investigating potential differ-
ences in the short-term habituation to pain in NSSI
compared to healthy controls.
We assess ANS response to painful stimulation using
measures of HR, HRV, and BP. One might critically note
that while we use a portable device to record HR and
HRV, a stationary assessment of ANS activity (e.g. using
a 3-lead electrocardiogram), is to be preferred. However,
as we were forced to compromise, we used a device
comparable to others, showing good validity and appear-
ing to be reliable [88–90]. Furthermore, the device has
been frequently used within other studies (e.g. [91, 92]).
The current and ongoing study will provide evidence
whether less pain sensitivity in adolescents with NSSI is
also associated with blunted physiological and endo-
crinological responses to experimentally induced pain
compared to healthy controls. Existing evidence on
altered pain sensitivity in NSSI is largely based on self-
reports of pain intensity and pain unpleasantness as well
as behavioural measures of pain threshold and tolerance.
This is the first study to take a systematic approach, and
evaluate ANS- and HPA-axis response to experimentally
induced pain in adolescent NSSI, extending the current
perspective on altered pain sensitivity in NSSI. Data
collection has an expected completion period of late
summer, 2015. A 1-year follow-up on the participants is
planned to further explore the temporal stability of alter-
ations in pain sensitivity in those engaging in NSSI,
reflected by psychophysiological and endocrinological
responses to experimentally induced pain.
Trial status
The study is ongoing and the first 20 participants have
been recruited.
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